Rikke Pordel Vind joined MC2 Therapeutics in March 2017 from a position as Senior Global Regulatory Lead, Research, at LEO Pharma A/S. Rikke has more than 25 years of experience within Regulatory Affairs working primarily with projects within R&D from the pre-clinical phase until registration. Further, Rikke has over the past years been involved in the regulatory evaluation of in-licensing opportunities.
Rikke have a broad regulatory background, a profound interest in the regulatory environment and in the competitive landscape, and combines this with a cross-functional mindset and a broad business understanding.
Rikke’s experience in Regulatory Affairs counts both small (Pharmexa A/S and LifeCycle Pharma A/S) and medium-size companies (LEO Pharma A/S and H. Lundbeck A/S). Rikke is cand.pharm and she has complemented with the exam in European Course in Pharmaceutical Medicine (ECPM) in Switzerland and in Project Management.